Literature DB >> 19410540

Blinded by the Light: The Growing Complexity of p53.

Karen H Vousden1, Carol Prives.   

Abstract

While the tumor suppressor functions of p53 have long been recognized, the contribution of p53 to numerous other aspects of disease and normal life is only now being appreciated. This burgeoning range of responses to p53 is reflected by an increasing variety of mechanisms through which p53 can function, although the ability to activate transcription remains key to p53's modus operandi. Control of p53's transcriptional activity is crucial for determining which p53 response is activated, a decision we must understand if we are to exploit efficiently the next generation of drugs that selectively activate or inhibit p53.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19410540     DOI: 10.1016/j.cell.2009.04.037

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  1442 in total

1.  A potential link between p53, cell competition and ribosomopathy in mammals and in Drosophila.

Authors:  Nicholas E Baker; Marianthi Kiparaki; Chaitali Khan
Journal:  Dev Biol       Date:  2018-12-02       Impact factor: 3.582

Review 2.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

3.  Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.

Authors:  Yi Zhang; Yan Cheng; Xingcong Ren; Tsukasa Hori; Kathryn J Huber-Keener; Li Zhang; Kai Lee Yap; David Liu; Lisa Shantz; Zheng-Hong Qin; Suping Zhang; Jianrong Wang; Hong-Gang Wang; Ie-Ming Shih; Jin-Ming Yang
Journal:  Cancer Res       Date:  2012-06-04       Impact factor: 12.701

4.  Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Authors:  Amrita Cheema; Chad D Knights; Mahadev Rao; Jason Catania; Ricardo Perez; Brigitte Simons; Sivanesan Dakshanamurthy; Vamsi K Kolukula; Maddalena Tilli; Priscilla A Furth; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 5.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

6.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 7.  Autophagy in endometriosis.

Authors:  Hui-Li Yang; Jie Mei; Kai-Kai Chang; Wen-Jie Zhou; Li-Qing Huang; Ming-Qing Li
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2.

Authors:  Simon M Vogel; Matthias R Bauer; Andreas C Joerger; Rainer Wilcken; Tobias Brandt; Dmitry B Veprintsev; Trevor J Rutherford; Alan R Fersht; Frank M Boeckler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

9.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

10.  Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.

Authors:  Monica Gostissa; Julia M Bianco; Daniel J Malkin; Jeffery L Kutok; Scott J Rodig; Herbert C Morse; Craig H Bassing; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.